About Kenneth Frazier
Kenneth Frazier is a director at Eikon Therapeutics.
Kenneth Frazier first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Kenneth Frazier in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kenneth Frazier works with at each company, as listed on that company's latest Form D.
Eikon Therapeutics, Inc. · Form D, Feb 28, 2025
RH
Robbie Huffines
Director
JW
Joshua Wolfe
Director
DB
Dror Berman
Director
JT
James Tananbaum
Director
LC
Leon Chen
Director
RW
Robin Washington
Director
RP
Roger Perlmutter
CEO and director